SCI Logo
 

SCI Technical and Business Interest Groups

Username:
Password:

 
 
Click here to go to the Chemistry & Industry web site
 
Click here to go to The SupplyLine web site
 
Click here to go to the Journal of the Science of Food and Agriculture web site
 
Click here to go to the Polymer International web site
 
Click here to go to the Pest Management Science web site
 
Click here to go to the Journal of Chemical Technology and Biotechnology web site
 
Click here to go to the Biofuels, Bioproducts and Biorefining (Biofpr) web site
 
 

Search SCI

Advance Search


Related Links

SCI Members' News index

Conference forum

Download page

Fine Chemicals Group

 

 

 

 




GPCRs in Medicinal Chemistry

8 - 10 September 2008

GPCRs in Medicinal Chemistry




Electronic laboratory notebooks proves to be a hot topic

Fine Chemicals Group: Electronic Laboratory Notebooks London, UK
9 February 2005


conference delegates

A hundred delegates from nine nations met at SCI International Headquarters in London’s Belgrave Square in early February to discuss ‘Electronic laboratory notebooks, challenges and solutions’.

This one-day meeting started with an entertaining and thought-provoking guide to the issues by Jeremy Frey, from Southampton University, followed by a detailed industry perspective from Paul Higginson of Pfizer. A refreshingly understandable review of patent law surrounding ELNs was provided by GSK’s James Kanagy. Following a busy lunchtime commercial exhibition, the afternoon session focussed on the experiences of scientists from AZ (Ian Menzies), Biovitrium (Mats Kihlén) and Kodak (Sheena Zuberi) in introducing, getting to grips with, and living in the world of electronic notebooks.

If proof were needed that ELNs are the topical issue this year, the lively discussion forum after tea confirmed it, with the debate continuing online (click here for our web forum). Stewart Rubenstein (Cambridgesoft) rounded off the day with a vendor’s view of the capabilities that electronic notebooks must provide.

This meeting brought together representatives from some 60 organisations including the chemical and pharma industries, universities and software vendors. Notably, many scientists attended as potential ELN users, along with IT experts and patent specialists. The day had a real buzz — surely a sign that this technology is taking off.

by David Witty, GSK